Obesity Paradox and 12 Month Outcome in Patients with Atrial Fibrillation

被引:8
|
作者
Rodriguez-Reyes, Humberto [1 ]
Lara-Vaca, Susano [2 ]
Ochoa-Guzman, Ana [3 ]
Chiquete, Erwin [4 ]
机构
[1] Hosp Cardiol Aguascalientes, Dept Cardiol, Aguascalientes, Aguascalientes, Mexico
[2] Unidad Med Alta Especialidad T1 IMSS, Dept Cardiol, Guanajuato, Mexico
[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unidad Biol Mol, Mexico City, DF, Mexico
[4] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Neurol & Psiquiatria, Mexico City, DF, Mexico
[5] Registro Mexicano Fibrilac Auricular, Mexico City, DF, Mexico
关键词
Arrhythmias; Antiarrhythmic; Atrial fibrillation; Mexico; Obesity paradox; Outcome; Registry; RHYTHM-CONTROL;
D O I
10.1016/j.arcmed.2020.10.015
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background and aim. Obesity increases the risk of atrial fibrillation (AF) while it may impact the outcome of patients with AF. The clinical implications of this relationship are not completely clear. We aimed to analyze the association of traditional anthropometric measures of excessive adiposity with 12 month case fatality rate (CFR) in patients with AF. Methods. This was a multicenter, longitudinal, observational study on adults with documented AF, excluding records of AF secondary to reversible causes. Anthropometric variables were registered at baseline, and a central committee validated the 12 month outcomes. Results. We studied 1193 patients (median age: 69.14 years, 55.2% women). At baseline, rhythm control was established for 476 (39.9%) subjects, while frequency control was offered to 717 (60.1%) participants. The 12 month all-cause CFR was 8.9%. A high basal body mass index (BMI), waist-to-height ratio (WHtR) and waist circumference (WC) were associated with lower CFR in bivariate analyses. In a Cox-proportional hazards model, variables associated with 12 month all-cause CFR were BMI categories (HR: 0.736, 95% CI: 0.584-0.928), chronic heart failure (HR: 1.738, 95% CI: 1.127-2.680), chronic kidney disease (HR: 2.269, 95% CI: 1.162-4.429) and carotid stenosis > 50% (HR: 5.342, 95% CI: 1.661-17.181). Conclusion. The risk of death at one year in patients with AF is inversely associated with a high BMI and directly associated with the presence of chronic kidney disease, carotid stenosis, and chronic heart failure in this cohort of patients with AF. The causes and implications of this apparent obesity paradox should be addressed in the future. (C) 2021 IMSS. Published by Elsevier Inc.
引用
收藏
页码:233 / 239
页数:7
相关论文
共 50 条
  • [21] Obesity Paradox in Cardiovascular Disease Revisited : The Impact of Obesity in Patients Hospitalized for Non Atrial Fibrillation Supraventricular Tachycardia
    Rodriguez, Mario
    Sabharwal, Basera
    Krittanawong, Chayakrit
    Rzechorzek, Wojciech
    Herzog, Eyal
    CIRCULATION, 2018, 138
  • [22] OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL
    Balla, Somasekhara R.
    Cyr, Derek
    Lokhnygina, Yuliya
    Becker, Richard
    Berkowitz, Scott
    Breithardt, Guenter
    Califf, Robert
    Fox, Keith
    Hacke, Werner
    Halperin, Jonathan
    Hankey, Graeme
    Mahaffey, Kenneth
    Nessel, Christopher
    Piccini, Jonathan
    Singer, Daniel
    Patel, Manesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A371 - A371
  • [23] The Obesity Paradox in patients with non-valvular atrial fibrillation: observations from the SPORTIF trials
    Proietti, M.
    Lane, D. A.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2016, 37 : 828 - 828
  • [24] Obesity Paradox in Atrial Fibrillation and its Relation with the New Ora Anticoagulants
    Novaes Lima Filho, Andre Inocencio
    Do Rego Barros, Mariana Costa
    de Barros Guimaraes, Alice Almeida
    Sobral Filho, Dario Celestino
    CURRENT CARDIOLOGY REVIEWS, 2022, 18 (05) : 8 - 10
  • [25] The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis on the obesity paradox
    Grymonprez, Maxim
    Capiau, Andreas
    De Backer, Tine L.
    Steurbaut, Stephane
    Boussery, Koen
    Lahousse, Lies
    CLINICAL CARDIOLOGY, 2021, 44 (05) : 599 - 608
  • [26] Outcome of Atrial Fibrillation in Patients With Sepsis
    Afzal, Benish
    Ali, Syed Ahsan
    Jamil, Bushra
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [27] Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
    Sandhu, Roopinder K.
    Ezekowitz, Justin A.
    Hijazi, Ziad
    Westerbergh, Johan
    Aulin, Julia
    Alexander, John H.
    Granger, Christopher B.
    Halvorsen, Sigrun
    Hanna, Michael S.
    Lopes, Renato D.
    Siegbahn, Agneta
    Wallentin, Lars
    OPEN HEART, 2018, 5 (02):
  • [28] Obesity Paradox on Outcome in Atrial Fibrillation Maintained Even Considering the Prognostic Influence of Biomarkers: Insights From the ARISTOTLE Trial
    Sandhu, Roopinder K.
    Ezekowitz, Justin
    Hijazi, Ziad
    Westerbergh, Johan
    Alexander, John H.
    Granger, Christopher B.
    Halvorsen, Sigrun
    Hanna, Michael S.
    Lopes, Renato D.
    Wallentin, Lars
    CIRCULATION, 2017, 136
  • [29] The Cholesterol Paradox in Atrial Fibrillation
    Femino, Raimondo
    Femino, Giovanni
    CIRCULATION JOURNAL, 2012, 76 (06) : 1537 - 1537
  • [30] "Cholesterol Paradox" in Atrial Fibrillation
    Suzuki, Shinya
    CIRCULATION JOURNAL, 2011, 75 (12) : 2749 - 2750